Review began 09/25/2022 review ended 09/27/2022 published 10/08/2022 © copyright

HIGHLIGHTS

• who: Report and colleagues from the General Hospital, Itoigawa, JPN have published the research: Review began 09/25/2022 Review ended 09/27/2022 Published 10/08/2022 u00a9 Copyright, in the Journal: (JOURNAL) of October/08,/2022
• what: The authors report a case with GBM and migraine, whose headache attributed to intracranial neoplasia and migraine without aura (code 1.1) were both successfully treated by fremanezumab.

SUMMARY

Glioblastoma (GBM), a World Health Organization (WHO) grade IV astrocytoma, representing 15 to 20% of all primary intracranial neoplasms in adults, is highly . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.